Huntsman Cancer Institute joins national clinical trial targeting AML

(Huntsman Cancer Institute) Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia& Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news